BPTS
Biophytis SA ADR

730
Mkt Cap
$1.89M
Volume
500.00
52W High
$3.36
52W Low
$0.001
PE Ratio
-0.05
BPTS Fundamentals
Price
$0.45
Prev Close
$0.45
Open
$0.45
50D MA
$0.2512
Beta
-2.08
Avg. Volume
13.50
EPS (Annual)
-$21.73
P/B
-0.12
Rev/Employee
$0.00
$12.11
Loading...
Loading...

About

Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and René Lafont on September 27, 2006 and is headquartered in Paris, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
20

Frequently Asked Questions

What is Market Cap of Biophytis - ADR?
What is the 52-week high for Biophytis - ADR?
What is the 52-week low for Biophytis - ADR?
What is Biophytis - ADR stock price today?
What was Biophytis - ADR stock price yesterday?
What is the PE ratio of Biophytis - ADR?
What is the Price-to-Book ratio of Biophytis - ADR?
What is the 50-day moving average of Biophytis - ADR?
How many employees does Biophytis - ADR have?

Latest BPTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.